Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone.
about
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain.Method of variability optimization in pharmacokinetic data analysis.Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles.A review of abuse-deterrent opioids for chronic nonmalignant pain.Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS(®) hydromorphone ER) in patients with chronic painUpdate on prescription extended-release opioids and appropriate patient selection.Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing.The pharmacokinetics of a long-acting OROS hydromorphone formulation.Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain.Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration.A new extended release formulation (OROS) of hydromorphone in the management of pain.Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain.A randomized study of the effects of food on the pharmacokinetics of once-daily extended-release hydromorphone in healthy volunteers.
P2860
Q33503399-9B1A2324-2F39-44E3-8175-1ECDB35EF847Q34777859-0E56B6F9-97F8-410D-81E3-79407BD2300BQ35168624-50403C74-FF34-4164-AA1A-31DAD703E9C0Q36137994-4D85D03E-2B16-4BFD-A7E1-CB1A10A8F52EQ36407485-E62463F2-CBE8-44AE-B4C0-B9CCAD603522Q37053718-53850097-2607-498E-BE6E-2952BAA34D72Q37392741-01F498F9-A7E9-4FDE-9175-71F8E063DF07Q37644498-8FC6D1C9-3488-4A3B-ADAD-A5E27ACB639CQ39321614-6EC2003F-4E12-4A88-9EAC-B41865186FCCQ39609528-850F56D5-70D6-4F88-A506-C52B3942061DQ41436187-341DB03B-FA2B-4A20-A1A6-EDE371B3D146Q50718496-578316C6-8ACE-486B-B073-47F427827918Q51386305-F6EFEA30-26DE-49B7-8D29-364572C1B91A
P2860
Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Pharmacokinetic investigation ...... formulation of hydromorphone.
@ast
Pharmacokinetic investigation ...... formulation of hydromorphone.
@en
type
label
Pharmacokinetic investigation ...... formulation of hydromorphone.
@ast
Pharmacokinetic investigation ...... formulation of hydromorphone.
@en
prefLabel
Pharmacokinetic investigation ...... formulation of hydromorphone.
@ast
Pharmacokinetic investigation ...... formulation of hydromorphone.
@en
P2093
P2860
P356
P1476
Pharmacokinetic investigation ...... formulation of hydromorphone.
@en
P2093
Gayatri Sathyan
John Thipphawong
Suneel K Gupta
P2860
P2888
P356
10.1186/1472-6904-7-3
P577
2007-02-02T00:00:00Z
P5875
P6179
1049408046